Application of Radiomics-based AI Models in Predicting Clinical Outcome of Patients With Renal Cell Carcinoma After Surgical Treatment

Recruiting now

Conditions studied: Renal Cell Carcinoma (Kidney Cancer)

In brief

This is a prospective observational cohort study (AI-Kidney-Prognosis), aiming to non-invasively predict the clinical outcomes in renal cell carcinoma patients after surgical treatment using radiomics-based AI models, thereby assisting clinical decision-making and personalized follow-up strategies.

Key facts

Study ID

NCT07118813

Run by

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

People needed

400

Starts

2025-08-01

Expected to finish

2026-08-01

Last updated by the study team

2025-08-12

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients were treated for renal cell carcinoma in Wuhan Union Hospital from August 2025 to August 2026;
• Aged > 18 years old;
• At least one abdominal CT scan before treatment;
• Tissue biopsy pathological examination confirmed the diagnosis of renal cell carcinoma.

You may not qualify if…

• Poor image quality;
• Incomplete clinical data or loss of follow-up;
• Presence of another primary malignancy other than renal cell carcinoma;
• Unclear pathological diagnosis.

Where it is running

• Union Hospital，Tongji Medical College，Huazhong University of Science and Technology — Wuhan, Hubei, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.